Jan 9, 2024

Moonwalk steps out with $57m for epigenetic reprogramming platform

Posted by in categories: biotech/medical, genetics

“Epigenetic changes determine whether genes are turned on or off, and can potentially reverse disease, broadening the therapeutic landscape to find potential cures previously thought impossible.”

Company co-founded by Alex Aravanis and Feng Zhang targets epigenetic code to reprogram cells to a healthy state.

Leave a reply